approval
saveMEKINIST (TRAMETINIB) — FDA approval
community read0 votes
Sponsor: NOVARTIS. Form: SOLUTION. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalMEKINIST (TRAMETINIB) — FDA approvalMar 26, 2026 · 192d ago
- approvalMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalMar 26, 2026 · 192d ago
- approvalMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalApr 21, 2025 · 531d ago
- approvalMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalApr 7, 2025 · 545d ago
- approvalMEKINIST (TRAMETINIB) — FDA approvalApr 7, 2025 · 545d ago
- approvalMEKINIST (TRAMETINIB) — FDA approvalMar 19, 2025 · 564d ago
- approvalMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalMar 19, 2025 · 564d ago
- approvalMEKINIST (TRAMETINIB) — FDA approvalMar 7, 2025 · 576d ago
same company · ±60 days · 6
- approvaldabrafenib mesylate ODT: TAFINLAR (DABRAFENIB MESYLATE) — FDA approvalFeb 27, 2024
- approvaldabrafenib mesylate ODT: TAFINLAR (DABRAFENIB MESYLATE) — FDA approvalFeb 27, 2024
- approvalSpexotras: MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalFeb 27, 2024
- approvalImatinib Mesylate Shilpa: GLEEVEC (IMATINIB MESYLATE) — FDA approvalMar 1, 2024
- approvaldabrafenib mesylate ODT: TAFINLAR (DABRAFENIB MESYLATE) — FDA approvalMar 29, 2024
- approvalSpexotras: MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalMar 29, 2024
comments(0)
5-min edit window · permanent after that